Durvalumab vs Norfloxacin

Durvalumab vs Norfloxacin: Overview

This comparison examines the pharmacological differences between Durvalumab and Norfloxacin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Norfloxacin: Second-generation fluoroquinolone inhibiting bacterial DNA gyrase and topoisomerase IV.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Norfloxacin — 3-4 hours.

Chemical Properties

Molecular Formula: Norfloxacin — C16H18FN3O3.

Molecular Weight: Norfloxacin — 319.3310 g/mol.

Type: Durvalumab — Antibody; Norfloxacin — Small molecule.